STOCK TITAN

Labcorp (NYSE: LH) to Webcast J.P. Morgan Healthcare Conference Chat

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Labcorp Holdings Inc. reported that it will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference. The session is scheduled for Tuesday, January 13 at 4:30 p.m. (PT) and will feature company representatives discussing Labcorp’s business with investors and industry participants.

The company will provide a live audio webcast of the fireside chat through its investor relations website at ir.Labcorp.com, and the recording will be archived for replay. Labcorp also furnished a press release dated December 30, 2025 as an exhibit, formally announcing its conference participation.

Positive

  • None.

Negative

  • None.
0000920148false00009201482025-12-302025-12-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
December 30, 2025
(Date of earliest event reported)
LABCORP HOLDINGS INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 1-11353 99-2588107
(State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

358 South Main Street 
Burlington,North Carolina27215
(Address of principal executive offices)(Zip Code)
(Registrant’s telephone number including area code) 336-229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of exchange on which registered
Common Stock, $0.10 par valueLHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 7.01Regulation FD Disclosure
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on December 30, 2025, that the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT). A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
Item 9.01
Financial Statements and Exhibits.

ExhibitExhibit Name
Exhibit 99.1
Press Release dated December 30, 2025 issued by Labcorp Holdings Inc.
Exhibit 104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABCORP HOLDINGS INC.
Registrant

 Date: December 30, 2025By:/s/ SANDRA VAN DER VAART
 Sandra van der Vaart
  Executive Vice President, Chief Legal Officer and Corporate Secretary



FAQ

What did Labcorp Holdings Inc. (LH) disclose in this 8-K?

Labcorp Holdings Inc. disclosed that it will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT), and that a related press release dated December 30, 2025 was furnished as an exhibit.

When is Labcorp (LH) presenting at the 44th Annual J.P. Morgan Healthcare Conference?

Labcorp is scheduled to participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT).

How can investors access Labcorp’s J.P. Morgan Healthcare Conference fireside chat?

Investors can access a live audio webcast of Labcorp’s fireside chat via the company’s investor relations website at ir.Labcorp.com, where it will also be archived for replay.

What exhibit did Labcorp (LH) include with this 8-K filing?

Labcorp included Exhibit 99.1, a press release dated December 30, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

Does this Labcorp 8-K include any new financial results or earnings data?

No, this 8-K focuses on Labcorp’s participation in an investor conference and the availability of a webcast, rather than providing financial results or earnings data.

Where is Labcorp Holdings Inc. headquartered?

Labcorp Holdings Inc. is headquartered at 358 South Main Street, Burlington, North Carolina 27215.

Labcorp Holdings Inc

NYSE:LH

LH Rankings

LH Latest News

LH Latest SEC Filings

LH Stock Data

20.97B
82.58M
0.34%
100.04%
3.31%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BURLINGTON